<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">
 <italic>mRNA-1273</italic> from Moderna is a lipid encapsulated mRNA vaccine and is undergoing safety and immune response phase I trial in Seattle. The company has filed for an IND to go for parallel phase II trials.
 <xref rid="bib61" ref-type="bibr">
  <sup>61</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib75" ref-type="bibr">
  <sup>75</sup>
 </xref>
</p>
